ILIT Life Settlements in New Jersey: A Trustee’s Guide

Why New Jersey ILITs Face a Decision Point

The irrevocable life insurance trust was the workhorse of New Jersey estate planning for decades, and for good reason. New Jersey had its own estate tax with an exemption that for many years sat at just $675,000 — the lowest in the nation — on top of a federal exemption that was $600,000 in the mid-1990s and only $2 million as recently as 2008. Families with a house in Bergen or Monmouth County and a retirement account routinely faced estate tax exposure, and the standard prescription was permanent life insurance owned by an ILIT to keep the death benefit out of the taxable estate and provide liquidity for the tax bill.

Both legs of that rationale have since collapsed for most families. The Tax Cuts and Jobs Act pushed the federal exemption above $13 million per individual. And New Jersey repealed its state estate tax entirely for deaths on or after January 1, 2018 — leaving only the inheritance tax, which does not touch transfers to spouses, children, and other Class A beneficiaries at all.

The result is a generation of New Jersey ILITs holding policies whose founding purpose has evaporated, while premium notices keep arriving. Grantors gifting $20,000 or $50,000 a year to fund coverage against a tax that no longer exists are, in effect, funding an investment that should be evaluated as one. The broader landscape is covered in the ILIT in a post-TCJA world; this guide focuses on the trustee’s specific question — what to do with the policy — and the settlement option many trustees never learn exists.

The Trustee’s Fiduciary Duties Under New Jersey Law

New Jersey trustees administer under the New Jersey Uniform Trust Code, which the state adopted in 2016, together with the trust instrument itself. The familiar fiduciary pillars apply with full force to a trust whose principal asset is a life insurance policy:

• Duty of prudent administration. The trustee must manage trust property as a prudent person would, considering the purposes and circumstances of the trust. A policy is trust property. Continuing to pay premiums on it — or letting it lapse — is an investment decision that must be reasoned, not reflexive.
• Duty of loyalty. Administration must serve the beneficiaries’ interests, not the trustee’s convenience or the grantor’s unexamined assumptions from 1998.
• Duty to monitor. Universal life policies are not static. Cost-of-insurance charges rise, crediting rates disappoint, and a policy illustrated to last to age 100 can quietly drift toward collapse at 87. A trustee who never orders an in-force illustration cannot claim to be monitoring anything.
• Duty of impartiality. Current and remainder beneficiaries may have different interests in cash now versus a death benefit later; the trustee must weigh both.

The exposure runs in both directions, which is what makes this genuinely hard. A trustee who lets a marketable policy lapse for zero may face beneficiary claims for the lost value; a trustee who surrenders for cash value without testing the secondary market may have left several multiples of that figure on the table, since the GAO found settlements pay roughly 4–8 times surrender value. The full duty framework is detailed in the ILIT trustee duties guide.

When a Trust-Owned Policy Becomes a Settlement Candidate

Not every ILIT policy should be sold — many should be kept, and the death benefit remains a uniquely efficient asset when it is still wanted and affordable. The settlement question becomes live when several of these markers align:

• The estate tax purpose is gone. The grantor’s estate falls comfortably below the $13 million-plus federal exemption, and New Jersey’s estate tax repeal removed the state-level exposure the trust was often built for.
• Premium funding is strained or resented. The grantor has stopped gifting, is reluctant to continue, or the trust lacks liquidity to carry the policy. Crummey-notice fatigue is often the first visible symptom.
• The policy itself is deteriorating. An in-force illustration shows rising cost-of-insurance charges pushing the policy toward lapse absent sharply higher funding — the dynamic explained in rising cost of insurance charges.
• The insured is 65 or older (or younger with significant health impairments), the face amount is $100,000 or more, and the policy has been in force at least two years — the market’s standard screens.
• Beneficiary circumstances changed. The children the trust was built for are now financially independent adults who may prefer educational funding for grandchildren, or simply a smaller certain benefit, over a distant contingent one.

When these align, the trustee’s job is not to sell — it is to price the alternatives. Surrender value from the carrier, market value from competitive bids, and the cost of continued funding, all in writing. Trustees who want the fuller decision tree should read life settlements for trustees alongside this guide.

Settlement vs. Surrender vs. Lapse Inside an ILIT

The three exits price very differently, and the spread between them is the heart of the trustee’s fiduciary exposure.

Lapse pays the trust nothing. After a missed premium and the 30–31 day grace period, coverage ends and every gifted dollar that funded the policy evaporates. For a trustee, an avoidable lapse of a marketable policy is the worst documented outcome possible — it converts trust property into nothing without a decision ever being made.

Surrender pays cash surrender value. Fast and simple, but for the older-insured, high-face policies that live inside New Jersey ILITs, surrender value routinely represents a small fraction of what the secondary market will pay. Surrendering without testing the market is the quieter fiduciary failure: the trust receives something, so no alarm sounds, but the delta went uncollected.

A life settlement pays market value into the trust — typically 10–35% of face, established through competitive bidding among licensed providers. It takes 60–120 days, requires medical records and two independent life expectancy reports (2–6 weeks), and closes through escrow.

There are intermediate options too: reducing the face amount, electing reduced paid-up status where available, or restructuring premiums — each preserving some death benefit at lower cost. The side-by-side analysis in ILIT surrender vs. settlement works through the arithmetic. The fiduciary point is not that settlement always wins; it is that a trustee cannot know which option wins without obtaining all the numbers, and the file should show that they did.

Trustee Option	Trust Receives	Death Benefit Outcome	Fiduciary Risk If Undocumented
Continue funding	Nothing now; death benefit later if premiums sustained	Preserved in full	Wasting trust resources on coverage without purpose; policy may still lapse later
Reduce face / paid-up election	Lower or no future premium obligation	Reduced but preserved	Under-analysis — middle options often never priced
Surrender	Cash surrender value	Lost	Accepting a fraction of market value without testing the market
Life settlement	Typically 10–35% of face value (4–8× surrender per GAO-10-775)	Lost (or reduced, if a retained death benefit is negotiated)	Poor process — single bid, unverified licenses, no comparison file
Allow lapse	Nothing	Lost	Highest — destruction of marketable trust property

Sale Mechanics: New Jersey Law and the Trustee as Seller

Life settlements in New Jersey are governed by the New Jersey Viatical Settlements Act, N.J.S.A. Title 17B, and regulated by the New Jersey Department of Banking and Insurance (DOBI). Brokers representing sellers and providers purchasing policies must be licensed in the state — and a trustee’s first diligence step is verifying those licenses with DOBI before sharing any trust or medical documents.

Trust ownership adds specific mechanics to the standard process:

• Confirm authority. The trust instrument and New Jersey trust law must permit the sale. Most ILIT documents grant broad powers over trust property; the trustee (or counsel) should confirm and memorialize this before marketing the policy.
• All trustees sign. Co-trustees must act per the instrument’s rules — jointly, by majority, or otherwise. Closing packages will require signatures matching the trust’s governing structure.
• The insured cooperates but does not sell. The grantor-insured signs medical release authorizations and will be subject to the buyer’s periodic health-status contact after closing, but the trust is the seller and the proceeds are trust property.
• Escrow protects the trust. Funds sit with an independent escrow agent until the carrier confirms the ownership change — standard practice the trustee should insist on, along with the post-closing rescission window (15–30 days is the national range) as a final safeguard.

The legal right to sell rests on Grigsby v. Russell (1911), and New Jersey’s framework tracks the NAIC Model Act. Trustees wanting the fuller state picture should see the NJ Viatical Settlements Act explained.

Tax Treatment When the Seller Is a Trust

The federal framework is the same three-tier structure that applies to individual sellers — Revenue Ruling 2009-13 as modified by the TCJA — but who reports the income depends on the trust’s tax character.

• Tier 1: proceeds up to the policy’s cost basis (aggregate premiums paid) are received tax-free.
• Tier 2: the amount between basis and cash surrender value is ordinary income.
• Tier 3: the excess over cash surrender value is capital gain.

Grantor trusts. Most ILITs are grantor trusts during the insured’s life, meaning the taxable tiers flow to the grantor’s personal return even though the trust receives the cash. Grantors should understand this before the trustee closes: the grantor may owe tax on money they never touch.

Non-grantor trusts report the income themselves, and compressed trust tax brackets reach the top federal rate at very low income levels — a real cost factor that belongs in the trustee’s comparison.

New Jersey overlay. New Jersey’s gross income tax offers no preferential capital-gains rate; taxable amounts are taxed at regular NJ rates. The state-specific arithmetic is covered in the New Jersey life settlement tax guide, and the federal tiers with worked examples in Revenue Ruling 2009-13 explained.

One more wrinkle: if the insured is terminally ill with a life expectancy under 24 months, IRC 101(g) may exclude proceeds entirely, though its application to trust-owned policies requires professional analysis. The IRS rules here are technical enough that no trustee should close without a CPA or tax counsel having reviewed the specific trust’s posture.

Documentation: The Trustee’s Real Protection

For a New Jersey trustee, the settlement decision will be judged years later, in hindsight, possibly by a beneficiary who wishes the outcome had been different. The defense is a file that shows a prudent process, whatever the conclusion was. Build it as you go:

• The trigger memo. A dated note recording why the policy came under review — grantor stopped gifting, illustration showed deterioration, purpose analysis after the estate tax repeal.
• The in-force illustration from the carrier, showing projected premiums and lapse horizon under current funding. This is the exhibit that proves the status quo was or wasn’t sustainable.
• The surrender value quote in writing — the floor every alternative must beat.
• License verifications. Printouts or confirmations from DOBI for every broker and provider involved.
• The auction record. Every bid, every round, with dates. Two independent life expectancy reports. Broker compensation disclosed in writing. This is what demonstrates market value was actually tested rather than assumed.
• The comparison analysis. Settlement net of costs and taxes, versus surrender, versus continued funding, versus reduced coverage — ideally with input from the trust’s CPA and counsel.
• Beneficiary communication. Notices or consents as the instrument and counsel advise; silence invites later dispute.
• Closing and escrow records, including confirmation the carrier processed the ownership change before funds released.

A trustee with this file has little to fear from either decision. A trustee without it is gambling that no beneficiary ever asks what the policy was worth. The vetting questions in questions to ask a life settlement broker slot directly into this record.

After the Sale: Redeploying Proceeds Inside the Trust

Settlement proceeds land in the trust, not in anyone’s pocket, and the trustee’s duties continue seamlessly: the cash is trust property to be administered under the instrument’s distribution and investment terms.

Distribution. If the instrument permits and the trust’s purpose is effectively complete, the trustee may distribute proceeds to beneficiaries — often the cleanest outcome for an ILIT whose estate-tax mission ended. Counsel should confirm the distribution standard and any tax consequences first.

Reinvestment. Alternatively, the trust holds and invests the proceeds under prudent investor principles. A trust that was consuming annual gifts now holds a liquid corpus that can grow, fund discretionary distributions, or await a remainder event.

Partial approaches. Some transactions preserve a retained death benefit — the trust keeps a reduced amount of coverage for beneficiaries while monetizing the rest — trading a lower cash payment for continued protection. For trusts with mixed beneficiary preferences, this middle path deserves pricing alongside the full sale.

Trust termination. Where the ILIT’s purpose is exhausted and the instrument or NJ trust law provides a path, counsel may recommend winding the trust up after distribution — ending Crummey administration, trustee fees, and tax filings for good.

Whatever the redeployment, close the loop in the file: a final memo recording where the proceeds went and why. The trustee who began with a purpose analysis and ends with a distribution memo has done exactly what New Jersey fiduciary law asks — managed trust property deliberately, in the beneficiaries’ interest, with the market tested and the numbers written down.

---

Frequently Asked Questions

Can an ILIT trustee legally sell a life insurance policy in New Jersey?

Yes, provided the trust instrument and New Jersey trust law grant the necessary authority, which most ILIT documents do through general powers over trust property. The sale itself is regulated under the New Jersey Viatical Settlements Act, N.J.S.A. Title 17B, and the brokers and providers involved must be licensed by the NJ Department of Banking and Insurance. The trustee signs as seller, proceeds are paid to the trust through escrow, and the insured grantor cooperates by authorizing medical record releases.

Is a trustee required to consider a life settlement before letting an ILIT policy lapse?

New Jersey fiduciary law requires prudent administration of trust property, and a life insurance policy is trust property with potentially substantial market value — GAO research found settlements pay roughly 4 to 8 times cash surrender value. A trustee who allows a marketable policy to lapse for nothing, or surrenders it without ever testing the secondary market, risks beneficiary claims for the value lost. Prudence doesn’t mandate selling; it mandates pricing the alternatives and documenting the comparison before deciding.

Who pays the taxes when an ILIT sells a policy in a life settlement?

It depends on the trust’s tax character. Most ILITs are grantor trusts during the insured’s lifetime, so the taxable tiers — ordinary income between basis and cash surrender value, capital gain above that — flow to the grantor’s personal return even though the trust receives the cash. Non-grantor trusts report the income themselves under compressed trust brackets that hit top rates quickly. New Jersey taxes the includable amounts at regular gross income tax rates. A CPA should model both layers before closing.

Do New Jersey ILITs still make sense now that the NJ estate tax is repealed?

Some do, some don’t. New Jersey repealed its estate tax for deaths on or after January 1, 2018, and the federal exemption now exceeds $13 million per person, so many ILITs lost their founding purpose. But trusts serving other goals — creditor protection, inheritance tax planning for non-Class A beneficiaries, spendthrift protection, or genuine liquidity needs in very large estates — retain value. The trustee’s job is a fresh purpose analysis: if the policy no longer serves one, its market value should be established before more premiums are gifted.

Do the trust beneficiaries have to approve the sale of an ILIT policy?

Usually the trust instrument, not the beneficiaries, controls — most ILITs empower the trustee to manage and dispose of trust property without beneficiary consent. That said, prudent New Jersey trustees often notify beneficiaries and sometimes obtain written acknowledgments, because informed beneficiaries rarely become litigating beneficiaries. Where co-trustees exist, the instrument’s rules on joint or majority action govern who must sign. Trust counsel should confirm the specific document’s requirements before the policy is marketed.

How long does an ILIT life settlement take in New Jersey?

Plan on 60 to 120 days, plus whatever time the trustee needs up front for authority review and counsel input. Medical records collection takes two to five weeks, two independent life expectancy reports take 2 to 6 weeks, competitive bidding among DOBI-licensed providers adds several weeks, and closing waits on the carrier confirming the ownership change before escrowed funds release to the trust. The trustee must keep premiums current throughout — the grace period is only 30–31 days, and a mid-process lapse destroys the asset.

What should an ILIT trustee document when deciding whether to sell a policy?

Build a file showing prudent process: a dated memo on why the policy came under review; the carrier’s in-force illustration and written surrender value; DOBI license verifications for every broker and provider; both life expectancy reports; every bid from every auction round; written broker compensation disclosure; a comparison of settlement versus surrender versus continued funding with tax input; beneficiary notices; and escrow and closing records. That file is the trustee’s protection regardless of which option is ultimately chosen.

Can the trust keep some death benefit and still do a life settlement?

Sometimes. Certain transactions can be structured with a retained death benefit: the trust monetizes the policy but keeps a reduced amount of coverage payable to the trust at the insured’s death, in exchange for a lower cash payment. For ILITs whose beneficiaries are divided — some preferring cash now, others valuing the legacy — this middle structure is worth pricing alongside a full sale, a surrender, and a face-reduction with the carrier. Availability depends on the policy and the bidding providers.

Related Reading

• Ilit Trustee Duties Guide
• Life Settlements New Jersey Complete Guide
• Nj Dobi Life Settlement Licensing
• Life Settlement Estate Tax Planning

---

Pine Lake Life Solutions does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.